Physician profile
Larry Laurich
NPI 1255326286
$223.16
in general payments reported to CMS, 2019-2025
10 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.68 · 2020: $12.40 · 2022: $27.52 · 2023: $31.48 · 2024: $20.33 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $68.18 | 2025 | Augment Injectable |
| Kowa Pharmaceuticals America, INC. | $31.48 | 2023 | Seglentis, Livalo |
| Lilly USA, LLC | $22.68 | 2019 | |
| Orthofix Medical, INC. | $20.83 | 2025 | Physio-Stim |
| Janssen Pharmaceuticals, INC | $20.33 | 2024 | Xarelto |
| Bioventus LLC | $15.87 | 2022 | |
| Pylant Medical | $13.78 | 2025 | |
| Novo Nordisk INC | $12.40 | 2020 | |
| Nevro Corp. | $11.65 | 2022 | |
| Biowound Solutions, INC. | $5.96 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Laurich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.